Report Detail
Global Anti-Obesity Therapeutics Market Insights, Forecast to 2025
- RnM3413013 |
- 20 July, 2020 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-Obesity Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Obesity Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Obesity Therapeutics market is segmented into
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs
Segment by Application, the Anti-Obesity Therapeutics market is segmented into
Hospital Use
Clinic Use
Household
Other
Regional and Country-level Analysis
The Anti-Obesity Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Obesity Therapeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Obesity Therapeutics Market Share Analysis
Anti-Obesity Therapeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Obesity Therapeutics business, the date to enter into the Anti-Obesity Therapeutics market, Anti-Obesity Therapeutics product introduction, recent developments, etc.
The major vendors covered:
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.
1 Study Coverage
- 1.1 Anti-Obesity Therapeutics Product Introduction
- 1.2 Market Segments
- 1.3 Key Anti-Obesity Therapeutics Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anti-Obesity Therapeutics Market Size Growth Rate by Type
- 1.4.2 Centrally Acting Anti-obesity Drugs
- 1.4.3 Peripherally Acting Anti-obesity Drugs
- 1.5 Market by Application
- 1.5.1 Global Anti-Obesity Therapeutics Market Size Growth Rate by Application
- 1.5.2 Hospital Use
- 1.5.3 Clinic Use
- 1.5.4 Household
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti-Obesity Therapeutics Market Size, Estimates and Forecasts
- 2.1.1 Global Anti-Obesity Therapeutics Revenue 2015-2026
- 2.1.2 Global Anti-Obesity Therapeutics Sales 2015-2026
- 2.2 Global Anti-Obesity Therapeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anti-Obesity Therapeutics Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anti-Obesity Therapeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-Obesity Therapeutics Competitor Landscape by Players
- 3.1 Anti-Obesity Therapeutics Sales by Manufacturers
- 3.1.1 Anti-Obesity Therapeutics Sales by Manufacturers (2015-2020)
- 3.1.2 Anti-Obesity Therapeutics Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anti-Obesity Therapeutics Revenue by Manufacturers
- 3.2.1 Anti-Obesity Therapeutics Revenue by Manufacturers (2015-2020)
- 3.2.2 Anti-Obesity Therapeutics Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anti-Obesity Therapeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anti-Obesity Therapeutics Revenue in 2019
- 3.2.5 Global Anti-Obesity Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anti-Obesity Therapeutics Price by Manufacturers
- 3.4 Anti-Obesity Therapeutics Manufacturing Base Distribution, Product Types
- 3.4.1 Anti-Obesity Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti-Obesity Therapeutics Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti-Obesity Therapeutics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anti-Obesity Therapeutics Market Size by Type (2015-2020)
- 4.1.1 Global Anti-Obesity Therapeutics Sales by Type (2015-2020)
- 4.1.2 Global Anti-Obesity Therapeutics Revenue by Type (2015-2020)
- 4.1.3 Anti-Obesity Therapeutics Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anti-Obesity Therapeutics Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anti-Obesity Therapeutics Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anti-Obesity Therapeutics Revenue Forecast by Type (2021-2026)
- 4.2.3 Anti-Obesity Therapeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anti-Obesity Therapeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anti-Obesity Therapeutics Market Size by Application (2015-2020)
- 5.1.1 Global Anti-Obesity Therapeutics Sales by Application (2015-2020)
- 5.1.2 Global Anti-Obesity Therapeutics Revenue by Application (2015-2020)
- 5.1.3 Anti-Obesity Therapeutics Price by Application (2015-2020)
- 5.2 Anti-Obesity Therapeutics Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anti-Obesity Therapeutics Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anti-Obesity Therapeutics Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anti-Obesity Therapeutics Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anti-Obesity Therapeutics by Country
- 6.1.1 North America Anti-Obesity Therapeutics Sales by Country
- 6.1.2 North America Anti-Obesity Therapeutics Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anti-Obesity Therapeutics Market Facts & Figures by Type
- 6.3 North America Anti-Obesity Therapeutics Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anti-Obesity Therapeutics by Country
- 7.1.1 Europe Anti-Obesity Therapeutics Sales by Country
- 7.1.2 Europe Anti-Obesity Therapeutics Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti-Obesity Therapeutics Market Facts & Figures by Type
- 7.3 Europe Anti-Obesity Therapeutics Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anti-Obesity Therapeutics by Region
- 8.1.1 Asia Pacific Anti-Obesity Therapeutics Sales by Region
- 8.1.2 Asia Pacific Anti-Obesity Therapeutics Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anti-Obesity Therapeutics Market Facts & Figures by Type
- 8.3 Asia Pacific Anti-Obesity Therapeutics Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anti-Obesity Therapeutics by Country
- 9.1.1 Latin America Anti-Obesity Therapeutics Sales by Country
- 9.1.2 Latin America Anti-Obesity Therapeutics Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anti-Obesity Therapeutics Market Facts & Figures by Type
- 9.3 Central & South America Anti-Obesity Therapeutics Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anti-Obesity Therapeutics by Country
- 10.1.1 Middle East and Africa Anti-Obesity Therapeutics Sales by Country
- 10.1.2 Middle East and Africa Anti-Obesity Therapeutics Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Anti-Obesity Therapeutics Market Facts & Figures by Type
- 10.3 Middle East and Africa Anti-Obesity Therapeutics Market Facts & Figures by Application
11 Company Profiles
- 11.1 Bristol-Myers Squibb
- 11.1.1 Bristol-Myers Squibb Corporation Information
- 11.1.2 Bristol-Myers Squibb Description and Business Overview
- 11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bristol-Myers Squibb Anti-Obesity Therapeutics Products Offered
- 11.1.5 Bristol-Myers Squibb Related Developments
- 11.2 Eisai Company
- 11.2.1 Eisai Company Corporation Information
- 11.2.2 Eisai Company Description and Business Overview
- 11.2.3 Eisai Company Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Eisai Company Anti-Obesity Therapeutics Products Offered
- 11.2.5 Eisai Company Related Developments
- 11.3 FlaxoSithKline plc.
- 11.3.1 FlaxoSithKline plc. Corporation Information
- 11.3.2 FlaxoSithKline plc. Description and Business Overview
- 11.3.3 FlaxoSithKline plc. Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 FlaxoSithKline plc. Anti-Obesity Therapeutics Products Offered
- 11.3.5 FlaxoSithKline plc. Related Developments
- 11.4 Novo Nordisk
- 11.4.1 Novo Nordisk Corporation Information
- 11.4.2 Novo Nordisk Description and Business Overview
- 11.4.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Novo Nordisk Anti-Obesity Therapeutics Products Offered
- 11.4.5 Novo Nordisk Related Developments
- 11.5 Alizyme
- 11.5.1 Alizyme Corporation Information
- 11.5.2 Alizyme Description and Business Overview
- 11.5.3 Alizyme Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Alizyme Anti-Obesity Therapeutics Products Offered
- 11.5.5 Alizyme Related Developments
- 11.6 BoehringerIngelheim GmbH
- 11.6.1 BoehringerIngelheim GmbH Corporation Information
- 11.6.2 BoehringerIngelheim GmbH Description and Business Overview
- 11.6.3 BoehringerIngelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Products Offered
- 11.6.5 BoehringerIngelheim GmbH Related Developments
- 11.7 Pfizer
- 11.7.1 Pfizer Corporation Information
- 11.7.2 Pfizer Description and Business Overview
- 11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Pfizer Anti-Obesity Therapeutics Products Offered
- 11.7.5 Pfizer Related Developments
- 11.8 Takeda Pharmaceutical
- 11.8.1 Takeda Pharmaceutical Corporation Information
- 11.8.2 Takeda Pharmaceutical Description and Business Overview
- 11.8.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Takeda Pharmaceutical Anti-Obesity Therapeutics Products Offered
- 11.8.5 Takeda Pharmaceutical Related Developments
- 11.9 Rhythm Pharmaceuticals
- 11.9.1 Rhythm Pharmaceuticals Corporation Information
- 11.9.2 Rhythm Pharmaceuticals Description and Business Overview
- 11.9.3 Rhythm Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Products Offered
- 11.9.5 Rhythm Pharmaceuticals Related Developments
- 11.10 Shionogi USA
- 11.10.1 Shionogi USA Corporation Information
- 11.10.2 Shionogi USA Description and Business Overview
- 11.10.3 Shionogi USA Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Shionogi USA Anti-Obesity Therapeutics Products Offered
- 11.10.5 Shionogi USA Related Developments
- 11.1 Bristol-Myers Squibb
- 11.1.1 Bristol-Myers Squibb Corporation Information
- 11.1.2 Bristol-Myers Squibb Description and Business Overview
- 11.1.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Bristol-Myers Squibb Anti-Obesity Therapeutics Products Offered
- 11.1.5 Bristol-Myers Squibb Related Developments
- 11.12 Zafgen
- 11.12.1 Zafgen Corporation Information
- 11.12.2 Zafgen Description and Business Overview
- 11.12.3 Zafgen Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Zafgen Products Offered
- 11.12.5 Zafgen Related Developments
- 11.13 Norgine Pharmaceuticals Ltd.
- 11.13.1 Norgine Pharmaceuticals Ltd. Corporation Information
- 11.13.2 Norgine Pharmaceuticals Ltd. Description and Business Overview
- 11.13.3 Norgine Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Norgine Pharmaceuticals Ltd. Products Offered
- 11.13.5 Norgine Pharmaceuticals Ltd. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anti-Obesity Therapeutics Market Estimates and Projections by Region
- 12.1.1 Global Anti-Obesity Therapeutics Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anti-Obesity Therapeutics Revenue Forecast by Regions 2021-2026
- 12.2 North America Anti-Obesity Therapeutics Market Size Forecast (2021-2026)
- 12.2.1 North America: Anti-Obesity Therapeutics Sales Forecast (2021-2026)
- 12.2.2 North America: Anti-Obesity Therapeutics Revenue Forecast (2021-2026)
- 12.2.3 North America: Anti-Obesity Therapeutics Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anti-Obesity Therapeutics Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anti-Obesity Therapeutics Sales Forecast (2021-2026)
- 12.3.2 Europe: Anti-Obesity Therapeutics Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anti-Obesity Therapeutics Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anti-Obesity Therapeutics Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anti-Obesity Therapeutics Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anti-Obesity Therapeutics Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anti-Obesity Therapeutics Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anti-Obesity Therapeutics Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anti-Obesity Therapeutics Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anti-Obesity Therapeutics Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anti-Obesity Therapeutics Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anti-Obesity Therapeutics Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anti-Obesity Therapeutics Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anti-Obesity Therapeutics Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anti-Obesity Therapeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anti-Obesity Therapeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti-Obesity Therapeutics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti-Obesity Therapeutics . Industry analysis & Market Report on Anti-Obesity Therapeutics is a syndicated market report, published as Global Anti-Obesity Therapeutics Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Anti-Obesity Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
